What is the MCID? HCP

Both clinical studies established that Eroxon® met and exceeded the Minimal Clinically Important Difference “MCID” (Rosen et al 2011). The MCID is an outcome measure that would be noticeable to a person using the product and be of clinical relevance.

An overall MCID of a 4-unit change over baseline using the IIEF-EF (International Index of Erectile Function – an internationally recognized and fully validated standard used in ED clinical trials) is used by leading experts in ED and regulatory authorities as a threshold for success in ED clinical studies.